VALDECOXIB - search results

United States - English - NLM (National Library of Medicine)

bextra- valdecoxib tablet, film coated

g.d. searle llc - valdecoxib (unii: 2919279q3w) (valdecoxib - unii:2919279q3w) - tablet, film coated - 10 mg - bextra tablets are indicated: - for relief of the signs and symptoms of osteoarthritis and adult rheumatoid arthritis. - for the treatment of primary dysmenorrhea. bextra should not be given to patients who have demonstrated allergic-type reactions to sulfonamides. bextra tablets are contraindicated in patients with known hypersensitivity to valdecoxib. bextra should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids are possible in such patients (see warnings — anaphylactoid reactions, and precautions — preexisting asthma). bextra is contraindicated for the treatment of post-operative pain immediately following coronary artery bypass graft (cabg) surgery and should not be used in this setting. (see clinical studies — safety studies).

New Zealand - English - Medsafe (Medicines Safety Authority)

bextra

pfizer new zealand limited - valdecoxib 10mg; ; - film coated tablet - 10 mg - active: valdecoxib 10mg excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose opadry white purified water starch

New Zealand - English - Medsafe (Medicines Safety Authority)

bextra

pfizer new zealand limited - valdecoxib 20mg; ; - film coated tablet - 20 mg - active: valdecoxib 20mg excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose opadry white purified water starch

New Zealand - English - Medsafe (Medicines Safety Authority)

bextra

pfizer new zealand limited - valdecoxib 40mg; ; - film coated tablet - 40 mg - active: valdecoxib 40mg excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose opadry white purified water starch

European Union - English - EMA (European Medicines Agency)

dynastat

pfizer europe ma eeig - parecoxib sodium - pain, postoperative - coxibs, antiinflammatory and antirheumatic products - for the short-term treatment of postoperative pain in adults.,